236 related articles for article (PubMed ID: 20197055)
21. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis.
Xu H; Zhou Y; Liu Y; Ping J; Shou Q; Chen F; Ruo R
J Endocrinol; 2016 May; 229(2):133-44. PubMed ID: 26941037
[TBL] [Abstract][Full Text] [Related]
22. FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis.
Wang C; Chi Y; Li J; Miao Y; Li S; Su W; Jia S; Chen Z; Du S; Zhang X; Zhou Y; Wu W; Zhu M; Wang Z; Yang H; Xu G; Wang S; Yang J; Guan Y
Hepatology; 2014 May; 59(5):1779-90. PubMed ID: 24806753
[TBL] [Abstract][Full Text] [Related]
23. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas.
Siempelkamp BD; Rathinaswamy MK; Jenkins ML; Burke JE
J Biol Chem; 2017 Jul; 292(29):12256-12266. PubMed ID: 28515318
[TBL] [Abstract][Full Text] [Related]
25. p110beta is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity.
Asano T; Kanda A; Katagiri H; Nawano M; Ogihara T; Inukai K; Anai M; Fukushima Y; Yazaki Y; Kikuchi M; Hooshmand-Rad R; Heldin CH; Oka Y; Funaki M
J Biol Chem; 2000 Jun; 275(23):17671-6. PubMed ID: 10748220
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.
Chen SH; Liu XN; Peng Y
J Cell Mol Med; 2019 Sep; 23(9):5895-5906. PubMed ID: 31287224
[TBL] [Abstract][Full Text] [Related]
27. Galpha16 interacts with Class IA phosphatidylinositol 3-kinases and inhibits Akt signaling.
Yeung WW; Wong YH
Cell Signal; 2010 Sep; 22(9):1379-87. PubMed ID: 20471473
[TBL] [Abstract][Full Text] [Related]
28. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
29. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
[TBL] [Abstract][Full Text] [Related]
30. PTEN-deficient cancers depend on PIK3CB.
Wee S; Wiederschain D; Maira SM; Loo A; Miller C; deBeaumont R; Stegmeier F; Yao YM; Lengauer C
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13057-62. PubMed ID: 18755892
[TBL] [Abstract][Full Text] [Related]
31. Adipose tissue insulin resistance due to loss of PI3K p110α leads to decreased energy expenditure and obesity.
Nelson VL; Jiang YP; Dickman KG; Ballou LM; Lin RZ
Am J Physiol Endocrinol Metab; 2014 May; 306(10):E1205-16. PubMed ID: 24691033
[TBL] [Abstract][Full Text] [Related]
32. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
Guillermet-Guibert J; Bjorklof K; Salpekar A; Gonella C; Ramadani F; Bilancio A; Meek S; Smith AJ; Okkenhaug K; Vanhaesebroeck B
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8292-7. PubMed ID: 18544649
[TBL] [Abstract][Full Text] [Related]
33. PI3-kinase p110α mediates β1 integrin-induced Akt activation and membrane protrusion during cell attachment and initial spreading.
Zeller KS; Idevall-Hagren O; Stefansson A; Velling T; Jackson SP; Downward J; Tengholm A; Johansson S
Cell Signal; 2010 Dec; 22(12):1838-48. PubMed ID: 20667469
[TBL] [Abstract][Full Text] [Related]
34. Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism.
Foukas LC; Bilanges B; Bettedi L; Pearce W; Ali K; Sancho S; Withers DJ; Vanhaesebroeck B
EMBO Mol Med; 2013 Apr; 5(4):563-71. PubMed ID: 23483710
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor-1 and PTEN deletion enhance cardiac L-type Ca2+ currents via increased PI3Kalpha/PKB signaling.
Sun H; Kerfant BG; Zhao D; Trivieri MG; Oudit GY; Penninger JM; Backx PH
Circ Res; 2006 Jun; 98(11):1390-7. PubMed ID: 16627784
[TBL] [Abstract][Full Text] [Related]
36. Activity of any class IA PI3K isoform can sustain cell proliferation and survival.
Foukas LC; Berenjeno IM; Gray A; Khwaja A; Vanhaesebroeck B
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11381-6. PubMed ID: 20534549
[TBL] [Abstract][Full Text] [Related]
37. The phosphatidylinositol 3-kinase (PI3K) isoform dependence of tumor formation is determined by the genetic mode of PI3K pathway activation rather than by tissue type.
Utermark T; Schmit F; Lee SH; Gao X; Schaffhausen BS; Roberts TM
J Virol; 2014 Sep; 88(18):10673-9. PubMed ID: 24991009
[TBL] [Abstract][Full Text] [Related]
38. Role of p110a subunit of PI3-kinase in skeletal muscle mitochondrial homeostasis and metabolism.
Li ME; Lauritzen HPMM; O'Neill BT; Wang CH; Cai W; Brandao BB; Sakaguchi M; Tao R; Hirshman MF; Softic S; Kahn CR
Nat Commun; 2019 Jul; 10(1):3412. PubMed ID: 31363081
[TBL] [Abstract][Full Text] [Related]
39. Role of phosphoinositide 3-OH kinase p110β in skeletal myogenesis.
Matheny RW; Riddle-Kottke MA; Leandry LA; Lynch CM; Abdalla MN; Geddis AV; Piper DR; Zhao JJ
Mol Cell Biol; 2015 Apr; 35(7):1182-96. PubMed ID: 25605332
[TBL] [Abstract][Full Text] [Related]
40. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit.
Ueki K; Algenstaedt P; Mauvais-Jarvis F; Kahn CR
Mol Cell Biol; 2000 Nov; 20(21):8035-46. PubMed ID: 11027274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
